It is specifically indicated for adult and pediatric patients aged 6 years and older with obesity caused by POMC, proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. This evidence concerns the gene POMC and obesity disorder.